NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for HIV Vaccine Trials Network


Results 1 - 13


Refine Search
Display Mode: Context | Summary
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope
2009 JUN 1 ... Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately ... is three times that of whites. Amidst this tragic reality, the ongoing search for an HIV vaccine gives us reason to hope. The HIV vaccine research field continues to advance, and 2009 ... not yet found a vaccine, there are reasons to be hopeful. Several large scale efficacy trials in humans have already been completed. While their results did not yield an effective ... HIV vaccine research through education and awareness building. Through its membership network of AIDS service organizations, health departments, health educators and community-based ...
Subject: HIV/AIDS
Price: $3.00
*
Data from S.P. Buchbinder and colleagues advance knowledge in HIV/AIDS
2009 JAN 5 ... Diseases, in the US National institutes of Health (NIH); and the NIH-sponsored HIV Vaccine Trials Network (HVTN)." Buchbinder and colleagues published their study in Lancet ...
Subject: HIV/AIDS
Price: $3.00
*
Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
2009 OCT 12 ... advanced to a Phase 2a human clinical trial, which was initiated in February 2009 by the HIV Vaccine Trials Network (HVTN) and continues to have steadily increasing enrollment. On the therapeutic vaccine, ...
Subject: HIV/AIDS
Price: $3.00
*
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
2009 JUL 6 ... being conducted in collaboration with the U.S. National Institutes of Health-sponsored HIV Vaccine Trials Network (HVTN). Planning is progressing well for initiating a therapeutic vaccination study in ...
Subject: HIV/AIDS
Price: $3.00
*
GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2009 AUG 24 ... are approved, the speed of enrollment increases. This trial is being conducted by the HIV Vaccine Trials Network (HVTN), funded and supported by the National Institutes of Allergy and Infectious ...
Subject: HIV/AIDS
Price: $3.00
*
GeoVax Labs, Inc. Provides Clinical Studies Update
2009 AUG 17 ... level of analysis, Phase 2a human clinical trial. This trial was initiated by the HIV Vaccine Trials Network (HVTN) in February this year and we are pleased to report that the HVTN has currently ...
Subject: HIV/AIDS
Price: $3.00
*
GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
2009 MAR 23 ... (NIH) support of our ongoing Phase 2a preventative clinical trial being conducted by the HIV Vaccine Trials Network (HVTN), and are further offset by the direct grant from the NIH to GeoVax, covering ...
Subject: Vaccines
Price: $3.00
*
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
2009 MAY 18 ... Maternal Pediatric Adolescent AIDS Clinical Trials Group, HIV Prevention Trials Network, HIV Vaccine Trials Network, and Microbicide Trials Network. The networks are an affiliated group of national and ...
Subject: HIV/AIDS
Price: $3.00
*
International Partnership for Microbicides Receives US $130 Million from UK Government and the Gates Foundation
2009 MAR 9 ... the Bill & Melinda Gates Foundation, reinforcing the global commitment to address the HIV epidemic in women. Globally, 7,000 new cases of HIV infection and almost ... women to protect themselves against infection and could be available long before a vaccine for HIV is found. New research is vital to halt this epidemic and we must increase our ... the encouraging results last month of a US National Institutes of Health Microbicide Trials Network clinical trial of the microbicide candidate PRO2000, which showed that the ...
Subject: HIV/AIDS
Price: $3.00
*
Quintiles Increases Capacity to Manage Clinical Studies for Diseases Including Malaria, HIV and Tuberculosis
2009 JUN 29 ... Quintiles Africa. "Initially the focus will be on diseases such as malaria, TB and HIV. However, we anticipate that as the infrastructure and economies in Africa develop, like ... West African countries, will immediately facilitate monitoring of a large malaria vaccine study now under way. The new Ghana office is based at the grounds of the ... Keywords: HIV/AIDS Co-Infection, Health, AIDS, Biotechnology, Clinical Trials, Infectious Diseases, Pharmaceutical, Pediatrics, Data Management, Economics, Economies, ... offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an ...
Subject: Quintiles
Price: $3.00
*
Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc.
2009 FEB 16 ... and Phase 1 clinical testing trials in humans. The human trial was conducted by the HIV Vaccine Trials Network (HVTN), and funded by the National Institute of Allergy and Infectious Disease (NIAID), ...
Subject: Standard & Poor’s
Price: $3.00
*
Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate
2009 NOV 2 ... and encourage cross-disciplinary collaborations to contribute to the discovery of an HIV/AIDS vaccine. As part of this partnership, the Ragon Institute and IAVI ... by the Institute that can be further developed and ultimately advanced to clinical trials with technical support from IAVI. In addition, this partnership is intended to ... productive exchanges among leading researchers affiliated with both IAVI and its network of scientific consortia and the Ragon Institute. "We are honored to be ...
Subject: The International AIDS Vaccine Initiative
Price: $3.00
*
Worlds first engineered T cell receptor trial opens with new cellular therapy for HIV
2009 NOV 16 ... first ever study using patients' cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new ... over 33 million people estimated to be living with HIV worldwide. No cure or effective vaccine yet exists. Current treatment regimens are based on combinations of different classed of ... and Laboratory Medicine alongside Pablo Tebas, MD, Director of the adult AIDS Clinical Trials Unit (ACTU), Department of Infectious Diseases Division at the University of ... care by Thomson Reuters. In addition UPHS includes a primary-care provider network; a faculty practice plan; home care, hospice, and nursing home; three multispecialty ...
Subject: Virology
Price: $3.00
*

Results 1 - 13




-----------------------
PR Login